A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis

Thyroid

Volumn 7, Issue 3, 1997, Pages 401-405

  De La Rosa, Raymond E ^a   Hennessey, James V ^b   Tucci, Joseph R ^c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CATABOLISM; DENSITOMETRY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; PRIORITY JOURNAL; THYROTOXICOSIS; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0030834340     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.401     Document Type: Article

References (21)

1. Crooks J, Murray PC, Wayne EJ 1959 Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q J Med 28:211-234.
2. Jannson S, Berg G, Lindstedt G, Michanek A, Nystrom E 1993 Overweight - A common problem among women treated for hyperthyroidism. Postgrad Med J 69:107-111.
3. Braverman LE, Utiger RD 1991 Introduction to thyrotoxicosis. In: Braverman LE, Utinger RD, (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 6th ed. JB Lippincott, Philadelphia, pp. 645-647.
4. Van Camp G, Bourdoux PP, Bonnyns MA 1992 Age influence on clinical features in hospitalized thyroid patients: Dissimilarity between clinical and laboratory-findings in adulthood. A retrospective study. Thyroidology 4:75-82.
5. Nordyke RA, Gilbert FI, Harada ASM 1988 Graves' disease: Influence of age on clinical findings. Arch Intern Med 148:626-663.
6. Feely J, Isles TE, Ratcliffe WA, Crooks J 1979 Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease. Clin Endocrinol (Oxf) 10:531-538.
7. Hamburger JI, Meier DA 1974 The relationship between thyroid function and obesity. Mich Med 72:443-445.
8. Hoogwerf BJ, Nuttall FQ 1984 Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med 76:963-970.
9. Asp AA, Merenich JA 1993 Weight gain after one year post-radioactive iodine therapy for Graves' disease. (Abstract No. 1639), 75th Annual Meeting, Endocrine Society. JCEM 460.
10. Nystrom E, Stenlof K, Lonn L, Tisell LE, Lundberg PA, Lindstedt G, Berg G, Michanek A, Sjostrom L 1994 Changes in Body Weight, Body Composition and Collagen Related Peptides After Treatment For Thyrotoxicosis. (Abstract No. 215), 68th Meeting, American Thyroid Association. Thyroid 4,S-1:S-19.
11. Rosen CJ, Adler RA 1992 Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75:1531-1534.
12. Diamond T, Vine J, Smart R, Butler P 1994 Thyrotoxic bone disease in women: A potentially reversible disorder. Ann Intern Med. 120:8-11.
13. Faber J, Galloe AM 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis. Eur J Endocrinol 130:350-356.
14. Schneider DL, Barrett-Connor EL, Morton DJ. 1994 Thyroid hormone use and bone mineral density in elderly women. JAMA 271:1245-1249.
15. Bray GA, Jordan HA, Sims EAH 1976 Evaluation of the obese patient 2. Clinical findings. JAMA 235:2008-2010.
16. Bray GA, Jordan HA, Sims EAH 1976 Evaluation of the obese patient 1. An algorithm. JAMA 235:1487-1491.
17. Carleton RA, Lasater TM, Assaf AR, Feldman HA, McKinlay S, and The Pawtucket Heart Health Program Writing Group. 1995 The Pawtucket Heart Health Program: Com-munity changes in cardiovascular risk factors and projected disease risk. Am J Pub Health 85:777-785.
18. Vaisman M, Noureza ACL, Araujo CGS, Nunis JDM, Oliveira FD, Annarumma MO 1995 (Abstract No. 95), 11th International Thyroid Congress. Thyroid 5,S-1:S-48.
19. Olsen BR, Klein I, Benner R, Burdett R, Trzepac Z, Levey P 1991 Muscle Strength in Thyrotoxicosis. Thyroid 1:137-141.
20. Wartofsky L. 1994 Bone disease in thyrotoxicosis. Hosp Pract 29:69-80.
21. Duncan W, Chan A, Solomon B, Wartofsky L 1994 Influ-ence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 4:183-190.